News & Press Releases


Beckman Coulter Life Sciences Acquires Cytobank Beckman Coulter Life Sciences today announced its acquisition of Cytobank, a privately held, single cell data analysis, software as a service (SaaS) company based in Santa Clara, California.
Product Security Update - Microsoft Remote Desktop Protocol Vulnerability Remote Code Execution vulnerability in Remote Desktop Services (RDC) (Bluekeep)
Beckman Coulter Expands Portfolio of Standardized ClearLLab IVD Reagents for the Clinical Flow Cytometry Lab New 10-Color System with Kaluza C Software Streamlines Workflow and QC Reporting for Flow Cytometric Leukemia & Lymphoma* Analysis
Vi-CELL BLU Vies for Top Spot in Cell Viability Analysis Global input from customers drove product innovation by Beckman Coulter Life Sciences
Beckman Coulter Life Sciences Enters Liquid Biopsy Partnership with Apostle Inc. (INDIANAPOLIS, INDIANA – February 28, 2019) – Beckman Coulter Life Sciences announces the launch of Apostle MiniMax™ High Efficiency Cell-Free DNA Isolation Kit through an exclusive partnership with Apostle, a liquid biopsy company.
Beckman Coulter Life Sciences Acquires Labcyte to Expand Laboratory Automation Business (INDIANAPOLIS, INDIANA – January 30, 2019) – Beckman Coulter Life Sciences today announced its acquisition of Labcyte, a privately held, acoustic liquid handling company based in San Jose, California.
Beckman Coulter Expands Portfolio of Standardized ClearLLab CE-IVD Reagents for the Clinical Flow Cytometry Lab MIAMI, US (January 14, 2019) ─ Beckman Coulter launches the ClearLLab 10C System for the clinical flow cytometry lab. The new system includes the first 10-colour CE-IVD panels of immunophenotyping reagents for both lymphoid and myeloid lineages. The tubes utilize DURA Innovations dry reagent technology for the panels, which requires no refrigeration.
Beckman Coulter Life Sciences Announces Research-Focused Beckman.com INDIANAPOLIS, USA (October 15, 2018) – For a quarter century, the Beckman Coulter name has been important to clinicians and researchers worldwide. For the latter group, there's a newer name to remember─Beckman Coulter Life Sciences─and a new website to bookmark: beckman.com.
Winner of First Global CARES HIV/AIDS Award Announced at IAS 2018 MIAMI, US (July 18, 2018) ─ A 28-year-old African community youth worker Evah Namakula, has won the first, global CARES HIV/AIDS award, designed to recognize ordinary people who have shown ‘care, dedication and commitment’ in their communities as part of the fight against the disease
Beckman Coulter Launches Kaluza C Flow Cytometry Software for Clinical Labs Miami, USA ─ (May 14, 2018) ─ Beckman Coulter Life Sciences has launched the Kaluza C Flow Cytometry Analysis Software, an advanced data analysis system for the clinical laboratory. The new software streamlines clinical QC reporting and addresses standardization issues in flow cytometry.
PC Maintenance Service Advisory Computer equipment is sometimes overlooked when considering routine maintenance of laboratory equipment. Your routine maintenance should include inspecting and cleaning (PC’s to avoid buildup of dust and debris that can contribute to overheating, fire or early failure.
BECKMAN COULTER LIFE SCIENCES LAUNCHES NEW FAMILY OF FFPE REAGENT KITS Single Chemistry System Extracts Total Nucleic Acid, DNA and/or RNA From Single FFPE Tissue Sample
FDA CLASSIFIES FIELD ACTION RELATED TO FC 500™ AND EPICS^® AS CLASS 1 RECALL (MIAMI – November 20, 2018) – Beckman Coulter Life Sciences today announced the previously communicated global voluntary recall launched in January 2018 related to the FC 500™ Series Flow Cytometers (FC 500), COULTER^® EPICS^® XL™ and COULTER^®EPICS^®XL-MCL™ Flow Cytometer with System II Software (together referred to as the EPICS) has been classified as Class 1 by the U.S. Food and Drug Administration (FDA).
Beckman Coulter Expands Detection Boundaries of CytoFLEX Flow Cytometry Platform Miami, USA ─ (September 5, 2017) ─ Beckman Coulter Life Sciences has opened up the possibilities for cancer researchers with the launch of the first flow cytometer to offer excitation sources across the visible spectrum in a standard configuration.
Latest Beckman Coulter Clinical Flow Cytometry Product Gains FDA Clearance Beckman Coulter Life Sciences has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its latest clinical flow cytometry product, the Navios EX flow cytometer
Beckman Coulter Highlights the First US IVD Test Delivering Flow Cytometric Leukemia and Lymphoma Analysis in the Routine Clinical Lab Beckman Coulter Life Sciences featured its pioneering in vitro diagnostic ClearLLab reagents at the 69th American Association for Clinical Chemistry (AACC) Annual Scientific Meeting and Clinical Laboratory Expo (CLE).
Beckman Coulter Expands Role of AQUIOS CL Flow Cytometer in Routine Labs Beckman Coulter has significantly expanded the workflow capabilities of its AQUIOS CL Flow Cytometer with the addition of the AQUIOS Designer Software, developed specifically to handle user-defined tests in the routine lab.
WannaCry Ransomware Cyberattack Update WannaCry ransomware first appeared on Friday, May 12, 2017. Since then, WannaCry has attacked computers worldwide—spreading itself across organizations’ networks by exploiting vulnerabilities in Microsoft® Windows® operating systems without the MS17-010 Microsoft security patch. WannaCry encrypts data on infected machines and demands ransom payments to decrypt the data.
Evolution of Flow Cytometry as a Drug Screening Platform Flow Cytometry is an established technology used in many research and clinical laboratories. The largest users are immunologists and haematologists who use it for cell sorting and analysis. Increasing requirements for processing larger numbers of patient samples led to the development of automated tube loading carousels and, later multiwall plate-based sampling systems. The high speed quantitative high content analysis of cells also makes flow cytometry an attractive technology for drug discovery applications and it is used at many stages of this process. Recently it is also finding a niche in drug screening laboratories sharing bench space with other high throughput technologies. Flow cytometry is becoming an ideal tool, particularly in an environment where primary cell-based assays are increasingly being deployed to monitor drug responses.
Beckman Coulter Unveils Next Generation Analytical Ultracentrifuge at Analytica 2016 Optima AUC Delivers Enhanced Optics and Improved Software to Open New Applications Beckman Coulter Life Sciences launches the new Optima AUC at this year’s Analytica: 25th International Trade Fair for Laboratory Technology, Analysis, Biotechnology and analytica conference, being held in Munich, Germany, from May 10-13, 2016. This next generation analytical ultracentrifuge has been developed with many enhanced capabilities.
Inventor of Beckman Coulter Life Sciences’ CytoFLEX Flow Cytometer Honored Joining Dr. Beckman and Wallace Coulter as Fellow of American Institute for Medical and Biological Engineering (AIMBE) Inventor of Beckman Coulter Life Sciences’ CytoFLEX Flow Cytometer Honored for his Engineering Innovation This honor follows in the footsteps of the founding fathers of the company, Dr. Arnold Beckman and Wallace Coulter, both previous fellows of this prestigious organization.
Beckman Coulter’s CytoFLEX LX Flow Cytometer Delivers High Complexity Cellular Analysis INDIANAPOLIS, USA – (Mar. 20, 2017) – Beckman Coulter Life Sciences continues to expand the multi-parameter capabilities of its patented CytoFLEX flow cytometer technology. Its latest model, the CytoFLEX LX, with up to six lasers and 21 fluorescent channels, delivers even more parameters with the same exceptional fluorescence sensitivity and superior nanoparticle detection demanded by high end researchers.
Beckman Coulter 'Green Lights' Innovation with Biomek i-Series Beckman Coulter Life Sciences 'Green Lights' Innovation With Biomek i-Series Automated Workstations Next-Generation Liquid Handling Platform Designed to Meet Evolving Workflow Priorities Indianapolis, Ind. (February 6, 2017) – Beckman Coulter Life Sciences re-emerges as an innovator in automated liquid handling solutions with today’s introduction of the Biomek i-Series Automated Workstations, at the 2017 international conference of the Society for Laboratory Automation and Screening in Washington D.C.
Launch of Optima AUC Advances Protein Analysis via Analytical Ultracentrifugation Combines the Power of a Centrifuge with Advanced Optical Detection Capabilities INDIANAPOLIS (January 27, 2017) ─ Beckman Coulter Life Sciences returns analytical ultracentrifugation (AUC) to the center of protein research and macromolecule characterization with the next-generation Optima AUC. The instrument is now available for use in labs around the world, and will be available for hands on interaction during the 61st Annual Meeting of the Biophysical Society, February 12-14, in New Orleans.
Beckman Coulter Life Sciences Launches New FFPE Isolation Reagent Kit FormaPure DNA is a High-Quality, Scalable Extraction Kit Optimized for Automation INDIANAPOLIS, IND. (October 20, 2016) – Today, at the American Society of Human Genetics Annual Meeting in Vancouver, Beckman Coulter Life Sciences launched FormaPure DNA, the newest addition to its growing portfolio of nucleic acid isolation, clean up and purification reagent kits. FormaPure DNA is a high-quality, scalable Formalin-Fixed Paraffin-Embedded (FFPE) DNA extraction kit that provides beyond fit-for-purpose flexibility. Most notably, it provides significant time savings in the form of reduced turnaround times and less than 15 minutes of hands-on time when automated on a Biomek liquid handler.
Beckman Coulter Launches the First 10-colour, CE IVD reagent for L&L analysis ClearLLab LS Lymphoid Screen Reagent improves accuracy and turnaround time, eliminating 14 workflow steps. Miami, USA (October 17, 2016) ─ Beckman Coulter Life Sciences further demonstrates its expertise in clinical flow cytometry with the launch of ClearLLab LS Lymphoid Screen Reagent, Europe’s first CE-marked 10-colour, 12 antibody reagent combination for leukaemia and lymphoma analysis.
Beckman Coulter Awards Two Educational Scholarships to Advanced Analytical Ultracentrifugation Workshop/Symposium Beckman Coulter Life Sciences continues its collaboration with one of the nation’s leading Industry/University Cooperative Research Centers (I/UCRC), by awarding scholarships to two young scientists using analytical ultracentrifugation in their research.
Beckman Coulter and Uganda National Health Service Pilot MIAMI, Fla. May 2, 2016 -- Beckman Coulter Life Sciences and The CARES Initiative to fight HIV/AIDS has partnered with the Uganda National Health Laboratory Service (UNHLS) within the Ministry of Health based in Kampala, Uganda. The partnership was formed to support a laboratory strengthening Pilot. The Pilot will run 12 months and focus on improving laboratory operational efficiencies within the country’s HIV testing centers.
Beckman Coulter Premieres Fast, Low Sample Volume Analyzer at INTERPHEX 2016 Indianapolis (April 25, 2016) – Beckman Coulter Life Sciences will unveil a fast, low sample volume bioanalyte analyzer, the Vi-CELL MetaFLEX, at INTERPHEX 2016. This year’s event, showcasing pharmaceutical and bioprocessing innovation, is being held in the Jacob K. Javits Convention Center, New York, April 26-28 2016. The new, small footprint system will be premiered at the company’s Booth # 1533.
Beckman Coulter Unveils Biomek Method Launcher Indianapolis, Ind. (February 29, 2016) – Beckman Coulter Life Sciences recently introduced Biomek Method Launcher, a software user-interface enhancement for running methods on Biomek Automated Workstations. The software add-on helps new and experienced operators set up and automate workflows with ease.
Beckman Coulter CARES Update Dear Concerned Advocacy for HIV/AIDS, It’s been a busy 2015 at Beckman Coulter Life Sciences as the Global Flow Cytometry Business Unit joins the mission to fight HIV/AIDS. During this past year there were a number of noteworthy milestones worth mention. First and foremost, Beckman Coulter Life Sciences has renewed commitment to bring innovative solutions for HIV patients. The AQUIOS CL was introduced into resource limited settings and achieved two stringent regulatory milestones: USFDA clearance and WHO Pre-Qualification. We are pleased to offer this platform for automated lab based testing in environments where expert Cytometry skills and staff turn-over are ongoing challenges.
Leading Cancer Research Lab Announced as Winner in Beckman Coulter’s $200,000 CytoFLEX Flow Cytometer Contest Indianapolis (December 14, 2015) – A leading European gene therapy research team has won a $200,000 CytoFLEX Flow Cytometer from Beckman Coulter Life Sciences. The contest was designed to explore innovative research solutions involving flow cytometry.
AQUIOS CL Flow Cytometer Wins Two Awards Year in International Business Awards Indianapolis (September 10, 2015) -Beckman Coulter Life Sciences has gained two prestigious business awards for its clinical flow cytometer, the Aquios CL Flow Cytometer – winning gold as Best New Product Feature of the Year for Pipeline Sample Processing and Silver in the Enterprise Product of the Year, both in the Best in Biz Awards 2015.
Beckman Coulter to donate $2,500 to AIDS Vancouver at IAS 2015 Indianapolis (July 2015) – As part of their commitment to support the fight against HIV/AIDS, Beckman Coulter Life Sciences is making a donation of $2,500 (USD) to the AIDS Vancouver charity at the 2015 International AIDS Society (IAS) Conference, being held at the Vancouver Convention Centre on July 19-22, 2015 in Vancouver, Canada. The funds will go to the charity’s Health Promotion Program.
FDA Clears AQUIOS CL Flow Cytometer For Routine Immunophenotyping Applications in US Clinical Labs Indianapolis (May 6, 2015) - Beckman Coulter’s new, automated AQUIOS CL Flow Cytometer has received clearance from the U.S. Food and Drug Administration (FDA) for use in the clinical laboratory.
New AQUIOS CL Clinical Cytometer* For Routine Applications in Clinical Lab Indianapolis (June 10, 2014)-Beckman Coulter Life Sciences is set to transform the use of flow cytometry in the routine, clinical laboratory with its latest offering, the Aquios CL Clinical Flow Cytometer. Fully automated, with a small footprint, the instrument is the first, authentic ‘LOAD & GO’ cytometry system.
Kaluza for Gallios Delivers Ease of Use, Analytical Power for Researchers Indianapolis (May 5, 2014) - Kaluza for Gallios software combines cutting edge data acquisition tools with remarkable ease of use to increase efficiency and performance in the cell characterization and analysis workflow of core research laboratories. Researchers at all levels of experience can learn the system quickly using this next generation acquisition software for the Beckman Coulter Gallios cytometer.
MoFlo® Astrios EQ from Beckman Coulter Life Sciences Delivers Simultaneous High-speed Cell Sorting and Sub-micron Particle Detection MIAMI – (April 30, 2014) – MoFlo Astrios EQ, a six-way jet-in-air sorter from Beckman Coulter Life Sciences, delivers patent pending enhanced dual forward scatter (eFSC) technology for simultaneous sorting and detection of particles from 200 nm to 30 µm in diameter. The instrument sets a new standard for flow cytometry core facilities, delivering high-speed cell sorting and micro-particle detection in a single package. Featuring detailed and precise forward scatter resolution, beadless drop sample handling and increased biosafety, Astrios EQ meets a range of analysis needs.
Beckman Coulter Life Sciences To Acquire Cytometer Maker Xitogen Indianapolis (April 22, 2014) - Beckman Coulter Life Sciences has entered into an agreement to acquire Xitogen Technologies Inc. together with Cytojene Corporation. Xitogen, a flow cytometer developer based in Suzhou and Dalian, China, will provide Beckman Coulter Life Sciences with both a strong operational base in the growing China market and a high quality research instrument to round out their world-class cytometry offering. The acquisition is subject to customary closing conditions and is expected to close in the second quarter of 2014.
Beckman Coulter Life Sciences Features Automated Solutions and Systems for NGS, Screening, Cell Analysis at SLAS 2014 Workshops Highlight Meeting, While Booth Presentations Add Depth
Beckman Coulter Life Sciences Mobile Demo Lab Highlights ASCB Conference Plans Indianapolis (December 12, 2013) A demonstration van on wheels, presentation of the inaugural ASCB Kaluza Prize and an exhibit offering innovative cell research technologies are the high points for Beckman Coulter Life Sciences at this year’s annual meeting of the American Society for Cell Biology (ASCB), which convenes December 14-18 at the Ernest N. Morial Convention Center in New Orleans.
Navios Flow Cytometer from Beckman Coulter Cleared for Diagnostic Use in U.S. and China Indianapolis (Oct. 1, 2013)- Beckman Coulter Life Sciences has received 510(k) clearance from the U.S. Food and Drug Administration and an Import Medical Device Registration Certificate from the China Food and DrugAdministration for the in vitro diagnostic use of the Navios flow cytometry system. In the U.S., the Navios flow cytometer is intended for immunophenotyping in conjunction with proprietary Navios tetra software and CYTO-STAT tetraCHROME reagents.
New $5,000 ASCB Kaluza Prize Supported by Beckman Coulter To Encourage Creative Graduate Student Research Bethesda, MD. (August 27, 2013)-A competition for a $5,000 prize to encourage excellence in research by a graduate student member of the American Society for Cell Biology (ASCB) was announced today by ASCB President Don Cleveland, PhD. The ASCB Kaluza Prize supported by Beckman Coulter, Inc., an international biomedical devices manufacturer, is named for the German mathematician Theodor Kaluza (1885-1954) who is the namesake of Beckman Coulter’s flow cytometry software system.
PerFix Reagent Kits from Beckman Coulter Life Sciences Deliver Probes, Antibodies into Cells Indianapolis (August 7, 2013) -PerFix-Expose1 and PerFix-nc1, innovative new reagent kits for intracellular staining from Beckman Coulter Life Sciences, minimize sample manipulation for a streamlined workflow that delivers high quality results. Developed for use on Beckman Coulter’s Gallios1 and Navios2 series flow cytometers and compatible with all Beckman Coulter Life Sciences’ fluorochromes, the kits enable a clear focus on the cytoplasmic and nuclear compartments of the cell.
Beckman Coulter Life Sciences Acquires Assets of ReaMetrix India Pvt. Ltd Indianapolis (August 1, 2013) - Beckman Coulter Life Sciences, an innovator in life science research, has acquired the flow cytometry business assets of ReaMetrix India Pvt. Ltd, a Bangalore-based life science technology company. The transaction provides Beckman Coulter Life Sciences with temperature-stable, single-dose, multi-color antibody cocktails targeting the HIV monitoring and clinical research markets.
Hematologic Diagnostics Go with the Flow (August 1, 2013) - Those diagnosing hematopathological disorders have been reaping the benefits of improved flow cytometry methodologies, though standardization of some techniques is still in the works.
Simplify and Accelerate Your Cell Separation with Automation (July 3, 2013) - Barry Stripp probably wouldn’t get very far without today’s advanced cell-isolation techniques. Stripp’s research hinges on isolating cells and studying them for their ability to repair and renew lung tissue. Using monoclonal antibodies to mark out different cell types, Stripp, who is director of the new Lung Stem Cell Program at Cedars-Sinai Medical Center in Beverly Hills, Calif., relies on “technologies that allow you to interrogate a large battery of markers,” he says.
Seminars- Technology Highlight CYTO 2013 Offerings from Beckman Coulter Life Sciences Indianapolis (May 19, 2013) - Presenting two seminars and seven poster sessions, Beckman Coulter Life Sciences will have a prominent role when CYTO 2013 convenes at the San Diego Convention Center May 19-22, 2013. In exhibit hall booth 602, the company will introduce a novel cell sorting enhancement to their MoFlo Astrios platform, along with industry leading instruments, antibodies, reagents, software and custom and contract manufacturing services for both research and clinical cytometry
Automated Cell Staining in Drug Discovery (April 9, 2013) - Cell and molecular biology become more integral pieces of the modern drug discovery process on a seemingly daily basis. Monitoring the interaction of cells and internal cellular activity provides vital information about cell health, changes in disease states, and the response of targets to potential therapeutic compounds.
Genetic Engineering News – Democratizing Flow Cytometry (March 15, 2013) - Due to advances on many fronts, from microfluidics to software, flow cytometry is being simplified so that it can be more readily used by a wider range of scientists and clinicians without special expertise. GEN recently spoke with technical representatives from a number of leading flow cytometry companies to get a sense of the latest instrument trends and to find out about the emergence of novel applications.
Buyers’ Guide: Flow Cytometers (February 15, 2013) - The ability to sort individual cells quickly based on their size or protein expression has had a significant, positive impact on any area of cell biology research or medicine in which a mixed population of cells needs to be sorted out. This is accomplished using flow cytometry, in which cells (or particles) in suspension are funneled single-file through a narrow opening that ends in a nozzle, such that droplets of fluid emerge one at a time. Each droplet may, or may not, contain one cell.
Beckman Coulter Life Sciences Acquires Blue Ocean Biomedical Brea, California (March 29, 2012) – Beckman Coulter Life Sciences has acquired Blue Ocean Biomedical, LLC, a Pembroke Pines, Florida-based manufacturer of automated flow cytometry systems and reagents. The transaction provides Beckman Coulter Life Sciences with low complexity analyzers that integrate automated sample preparation and directly address emerging flow cytometry market trends.
Kaluza 1.2 Cytometry Software from Beckman Coulter Provides World-class Speed, Enhanced Ease of Use California (January 17, 2012) - Kaluza 1.2 from Beckman Coulter, Inc., an enhanced version of the company’s highly acclaimed flow cytometry software, adds new multiple visualization tools and processes data at blazing speeds, allowing scientists to focus on their research.A quick and simple interface with radial menus makes use easier than ever before. The ability to see animated data in multiple dimensions facilitates outstanding visualization. Additionally, millions of cells can be analyzed in an instant through the simultaneous use of hundreds of graphic processors, delivering lightning-fast processing speed.

Beckman Coulter Life Sciences Acquires Cytobank

Beckman Coulter Life Sciences today announced its acquisition of Cytobank, a privately held, single cell data analysis, software as a service (SaaS) company based in Santa Clara, California.

Product Security Update - Microsoft Remote Desktop Protocol Vulnerability

Remote Code Execution vulnerability in Remote Desktop Services (RDC) (Bluekeep)

Beckman Coulter Expands Portfolio of Standardized ClearLLab IVD Reagents for the Clinical Flow Cytometry Lab

New 10-Color System with Kaluza C Software Streamlines Workflow and QC Reporting for Flow Cytometric Leukemia & Lymphoma* Analysis

Cell Viability Vi-CELL BLU with carousel

Vi-CELL BLU Vies for Top Spot in Cell Viability Analysis

Global input from customers drove product innovation by Beckman Coulter Life Sciences

Beckman Coulter Life Sciences Enters Liquid Biopsy Partnership with Apostle Inc.

(INDIANAPOLIS, INDIANA – February 28, 2019) – Beckman Coulter Life Sciences announces the launch of Apostle MiniMax™ High Efficiency Cell-Free DNA Isolation Kit through an exclusive partnership with Apostle, a liquid biopsy company.

Beckman Coulter Life Sciences Acquires Labcyte to Expand Laboratory Automation Business

(INDIANAPOLIS, INDIANA – January 30, 2019) – Beckman Coulter Life Sciences today announced its acquisition of Labcyte, a privately held, acoustic liquid handling company based in San Jose, California.

Beckman Coulter Expands Portfolio of Standardized ClearLLab CE-IVD Reagents for the Clinical Flow Cytometry Lab

MIAMI, US (January 14, 2019) ─ Beckman Coulter launches the ClearLLab 10C System for the clinical flow cytometry lab. The new system includes the first 10-colour CE-IVD panels of immunophenotyping reagents for both lymphoid and myeloid lineages. The tubes utilize DURA Innovations dry reagent technology for the panels, which requires no refrigeration.

New Research-Focused Website Beckman.com

Beckman Coulter Expands Detection Boundaries of CytoFLEX Flow Cytometry Platform

Miami, USA ─ (September 5, 2017) ─ Beckman Coulter Life Sciences has opened up the possibilities for cancer researchers with the launch of the first flow cytometer to offer excitation sources across the visible spectrum in a standard configuration.

Latest Beckman Coulter Clinical Flow Cytometry Product Gains FDA Clearance

Beckman Coulter Life Sciences has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its latest clinical flow cytometry product, the Navios EX flow cytometer

Beckman Coulter Highlights the First US IVD Test Delivering Flow Cytometric Leukemia and Lymphoma Analysis in the Routine Clinical Lab

Beckman Coulter Life Sciences featured its pioneering in vitro diagnostic ClearLLab reagents at the 69th American Association for Clinical Chemistry (AACC) Annual Scientific Meeting and Clinical Laboratory Expo (CLE).

Beckman Coulter Expands Role of AQUIOS CL Flow Cytometer in Routine Labs

Beckman Coulter has significantly expanded the workflow capabilities of its AQUIOS CL Flow Cytometer with the addition of the AQUIOS Designer Software, developed specifically to handle user-defined tests in the routine lab.

WannaCry Ransomware Cyberattack Update

WannaCry ransomware first appeared on Friday, May 12, 2017. Since then, WannaCry has attacked computers worldwide—spreading itself across organizations’ networks by exploiting vulnerabilities in Microsoft® Windows® operating systems without the MS17-010 Microsoft security patch. WannaCry encrypts data on infected machines and demands ransom payments to decrypt the data.

Evolution of Flow Cytometry as a Drug Screening Platform

Flow Cytometry is an established technology used in many research and clinical laboratories. The largest users are immunologists and haematologists who use it for cell sorting and analysis. Increasing requirements for processing larger numbers of patient samples led to the development of automated tube loading carousels and, later multiwall plate-based sampling systems. The high speed quantitative high content analysis of cells also makes flow cytometry an attractive technology for drug discovery applications and it is used at many stages of this process. Recently it is also finding a niche in drug screening laboratories sharing bench space with other high throughput technologies. Flow cytometry is becoming an ideal tool, particularly in an environment where primary cell-based assays are increasingly being deployed to monitor drug responses.

Beckman Coulter Unveils Next Generation Analytical Ultracentrifuge at Analytica 2016

Optima AUC Delivers Enhanced Optics and Improved Software to Open New Applications

Beckman Coulter Life Sciences launches the new Optima AUC at this year’s Analytica: 25th International Trade Fair for Laboratory Technology, Analysis, Biotechnology and analytica conference, being held in Munich, Germany, from May 10-13, 2016. This next generation analytical ultracentrifuge has been developed with many enhanced capabilities.